Why Palantir Technologies Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Shares of Palantir Technologies Inc. (NYSE:PLTR) rose sharply during today’s pre-market trading after the company reported better-than-expected fourth-quarter sales results and issued guidance.
Palantir said fourth-quarter revenue increased 20% year-over-year to $608 million, which beat the consensus estimate of $602.41 million, according to Benzinga Pro. Palantir reported quarterly adjusted earnings of 8 cents per share, which was in line with analyst estimates.
Palantir expects first-quarter revenue to be between $612 million and $616 million versus estimates of $617.21 million. First-quarter adjusted income from operations is expected to be between $196 million and $200 million.
Palantir Technologies shares jumped 18.2% to $19.77 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
- InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) gained 54.2% to $0.3424 in pre-market trading after dipping around 26% on Monday.
- Chenghe Acquisition Co. (NASDAQ:CHEA) shares jumped 43.2% to $10.08 in pre-market trading. Chenghe Acquisition shares jumped 28% on Monday after shareholders on Friday voted to approve the merger agreement with Taiwan Color Optics, Inc.
- Exicure, Inc. (NASDAQ:XCUR) gained 36.2% to $0.75 in pre-market trading after the company announced it entered into a patent license agreement with Bluejay Therapeutics to develop cavrotolimod for the potential treatment for hepatitis.
- Gorilla Technology Group Inc. (NASDAQ:GRRR) shares gained 17.4% to $1.28 in pre-market trading. Gorilla Technology shares jumped 96% on Monday after the company reported results through the third quarter of 2023.
- NanoString Technologies, Inc. (NASDAQ:NSTG) shares gained 13.7% to $0.1171 in pre-market trading. NanoString Technologies shares dipped 78% on Monday after the company initiated voluntary Chapter 11 restructuring proceedings.
- Sangamo Therapeutics, Inc. (NASDAQ:SGMO) shares rose 12.3% to $0.6289 in pre-market trading after reporting updated preliminary data from Phase 1/2 STAAR clinical study evaluating Isaralgagene Civaparvovec, or ST-920.
- SOS Limited (NYSE:SOS) shares rose 10.7% to $3.32 in pre-market trading after dipping more than 7% on Monday.
- Vicarious Surgical Inc. (NYSE:RBOT) gained 10.4% to $0.43 in pre-market trading. Vicarious Surgical recently named Randy Clark as President.
- Airgain, Inc. (NASDAQ:AIRG) shares rose 8.8% to $4.90 in pre-market trading.
Losers
- Peraso Inc. (NASDAQ:PRSO) declined 29.5% to $2.15 in pre-market trading after dipping around 25% on Monday.
- Trio Petroleum Corp. (NYSE:TPET) fell 28.1% to $0.1545 in pre-market trading.
- Trio Petroleum issued an update on its operations in Monterey County, California.
- Symbotic Inc. (NASDAQ:SYM) fell 21.2% to $2.15 in pre-market trading after the company reported mixed first-quarter financial results.
- FMC Corporation (NYSE:FMC) shares declined 15.4% to $51.10 in pre-market trading after the company reported worse-than-expected fourth-quarter results.
- C3is Inc. (NASDAQ:CISS) shares declined 12.2% to $0.1302 in pre-market trading. C3is shares fell around 8% on Monday after the company filed for an offering of 43.75 million units.
- Crown ElectroKinetics Corp. (NASDAQ:CRKN) shares dipped 10.8% to $0.1059 in pre-market trading after declining over 3% on Monday.
- Rambus Inc. (NASDAQ:RMBS) shares fell 10.4% to $61.20 in pre-market trading after the company reported mixed quarterly financial results.
- Elevai Labs, Inc. (NASDAQ:ELAB) shares declined 10.2% to $0.68 in pre-market trading after dipping around 9% on Monday.
- Nyxoah S.A. (NASDAQ:NYXH) shares fell 10% to $9.65 in pre-market trading.
- Chegg, Inc. (NYSE:CHGG) shares declined 8.8% to $8.48 in pre-market trading after the company issued weak first-quarter guidance.
Now Read This: Ford, Eli Lilly And 3 Stocks To Watch Heading Into Tuesday
